Showing results (1221-1230 of 1,893) with videos related to

Sort By:
Pageof 190
Immunotherapy|September 5, 2014
Cancer CARtography: charting out a new approach to cancer immunotherapyJaina M Patel, Gordon A Dale, Vincent F Vartabedian, et al.
Immunotherapy|September 5, 2014
Cytokine-induced killer cells in the treatment of patients with renal cell carcinoma: a pooled meta-analysisZheng-Xu Wang, Jun-Li Li, Jun-Xia Cao, et al.
Immunotherapy|November 10, 2020
Ixekizumab in the treatment of psoriatic arthritisEric Lespessailles, Hechmi Toumi
Immunotherapy|November 5, 2020
Restricted mean survival time as outcome measure in advanced urothelial bladder cancer: analysis of 4 clinical studiesMelania Rivano, Luca Cancanelli, Lorenzo Di Spazio, et al.
Immunotherapy|November 11, 2020
Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findingsHorst-Dieter Hummel, Peter Kufer, Carsten Grüllich, et al.
Immunotherapy|July 27, 2022
Late-onset toxicities of monoclonal antibodies in cancer patientsMai Alalawi, Abrar Saeed Bakr, Rowaida Reda, et al.
Immunotherapy|July 27, 2022
Development and characterization of anti-SARS-CoV-2 intravenous immunoglobulin from COVID-19 convalescent plasmaMikhail Razumikhin, Tatiana Smolyanova, Alevtina Nikolaeva, et al.
Immunotherapy|July 21, 2022
Pegcetacoplan treatment for geographic atrophy due to age-related macular degeneration: a plain language summary of the FILLY studyDavid S Liao, Ravi Metlapally, Preeti Joshi
Immunotherapy|January 26, 2016
CD73-adenosine: a next-generation target in immuno-oncologyDavid Allard, Bertrand Allard, Pierre-Olivier Gaudreau, et al.
Immunotherapy|February 11, 2016
A review of allergoid immunotherapy: is cat allergy a suitable target?Nhung T Nguyen, Esther Raskopf, Kija Shah-Hosseini, et al.
Pageof 190